These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 24225201)

  • 101. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Prescribing patterns to optimize heart rate: analysis of 1,000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period.
    Dierckx R; Cleland JG; Parsons S; Putzu P; Pellicori P; Dicken B; Boyalla V; Clark AL
    JACC Heart Fail; 2015 Mar; 3(3):224-30. PubMed ID: 25650369
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial.
    Rossi A; Inciardi RM; Rossi A; Temporelli PL; Lucci D; Gonzini L; Marchioli R; Nicolosi GL; Tavazzi L;
    Pulm Pharmacol Ther; 2017 Jun; 44():16-23. PubMed ID: 28263812
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Effect of ivabradine on pulmonary hypertension in chronic obstructive pulmonary disease].
    Akhmetzianova ÉKh; Gaĭnitdinova VV; Bakirov AB; Bogoroditskaia OA; Timershina IR
    Kardiologiia; 2012; 52(2):41-6. PubMed ID: 22792738
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT.
    Voors AA; van Veldhuisen DJ; Robertson M; Ford I; Borer JS; Böhm M; Komajda M; Swedberg K; Tavazzi L;
    Eur J Heart Fail; 2014 Apr; 16(4):426-34. PubMed ID: 24504937
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The cost effectiveness of ivabradine in the treatment of chronic heart failure from the U.K. National Health Service perspective.
    Griffiths A; Paracha N; Davies A; Branscombe N; Cowie MR; Sculpher M
    Heart; 2014 Jul; 100(13):1031-6. PubMed ID: 24634022
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial.
    Fiuzat M; Wojdyla D; Kitzman D; Fleg J; Keteyian SJ; Kraus WE; Piña IL; Whellan D; O'Connor CM
    J Am Coll Cardiol; 2012 Jul; 60(3):208-15. PubMed ID: 22560018
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The impact of heart failure and chronic obstructive pulmonary disease on mortality in patients presenting with breathlessness.
    Cuthbert JJ; Kearsley JW; Kazmi S; Kallvikbakka-Bennett A; Weston J; Davis J; Rimmer S; Clark AL
    Clin Res Cardiol; 2019 Feb; 108(2):185-193. PubMed ID: 30091083
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Antianginal efficacy and tolerability of ivabradine in the therapy of patients with stable angina: results of the CONTROL study].
    Glezer MG; Saĭgitov RT
    Kardiologiia; 2010; 50(11):65-75. PubMed ID: 21526568
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　- A Randomized, Double-Blind, Placebo-Controlled Phase II Study.
    Tsutsui H; Momomura S; Yamashina A; Ogawa H; Shimokawa H; Kihara Y; Saito Y; Hagiwara N; Ito H; Ako J; Inomata T; Tanaka T; Kawasaki Y;
    Circ J; 2016; 80(3):668-76. PubMed ID: 26763489
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Effects of heart rate reduction with ivabradine on the international ındex of erectile function (IIEF-5) in patients with heart failure.
    Mert KU; Dural M; Mert GÖ; Iskenderov K; Özen A
    Aging Male; 2018 Jun; 21(2):93-98. PubMed ID: 28844168
    [TBL] [Abstract][Full Text] [Related]  

  • 113. [Efficacy of therapy with bisoprolol and ivabradine in patients with ischemic heart disease combined with chronic obstructive pulmonary disease assessment of parameters of 24-hour ECG monitoring].
    Grigor'eva NIu
    Kardiologiia; 2009; 49(7-8):38-41. PubMed ID: 19656105
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-"Expanding arena for ivabradine".
    Priti K; Ranwa BL; Gokhroo RK; Kishore K; Bisht DS; Gupta S
    Cardiovasc Ther; 2017 Aug; 35(4):. PubMed ID: 28423233
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT.
    Komajda M; Tavazzi L; Swedberg K; Böhm M; Borer JS; Moyne A; Ford I;
    Eur J Heart Fail; 2016 Sep; 18(9):1182-9. PubMed ID: 27210035
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Differential impacts of achieved heart rate and achieved dose of β-blocker on clinical outcomes in heart failure with and without atrial fibrillation.
    Kato N; Kinugawa K; Teruhiko I; Hironori M; Hisataka M; Toshiro I; Masaru H; Atsushi Y; Nagai R
    Int J Cardiol; 2014 May; 173(2):331-3. PubMed ID: 24680244
    [No Abstract]   [Full Text] [Related]  

  • 117. Cost-Effectiveness of Ivabradine in the Treatment of Chronic Heart Failure.
    Adena MA; Hamann G; Sindone AP
    Heart Lung Circ; 2019 Mar; 28(3):414-422. PubMed ID: 29449079
    [TBL] [Abstract][Full Text] [Related]  

  • 118. PredischaRge initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial.
    Mentz RJ; DeVore AD; Tasissa G; Heitner JF; Piña IL; Lala A; Cole RT; Lanfear DD; Patel CB; Ginwalla M; Old W; Salacata AS; Bigelow R; Fonarow GC; Hernandez AF
    Am Heart J; 2020 May; 223():98-105. PubMed ID: 32217365
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Heart rate and its reduction in chronic heart failure and beyond.
    Nikolovska Vukadinović A; Vukadinović D; Borer J; Cowie M; Komajda M; Lainscak M; Swedberg K; Böhm M
    Eur J Heart Fail; 2017 Oct; 19(10):1230-1241. PubMed ID: 28627045
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial.
    Canepa M; Temporelli PL; Rossi A; Rossi A; Gonzini L; Nicolosi GL; Staszewsky L; Marchioli R; Maggioni AP; Tavazzi L;
    Cardiology; 2017; 136(2):128-137. PubMed ID: 27618363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.